Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 9:77:102793.
doi: 10.1016/j.eclinm.2024.102793. eCollection 2024 Nov.

Multi-methods process evaluation of the SToP (See, Treat, Prevent) trial: a cluster randomised, stepped wedge trial to support healthy skin

Collaborators, Affiliations

Multi-methods process evaluation of the SToP (See, Treat, Prevent) trial: a cluster randomised, stepped wedge trial to support healthy skin

Hannah M M Thomas et al. EClinicalMedicine. .

Abstract

Background: Healthy skin is important for maintaining overall physical and cultural health and wellbeing. However, remote-living Australian Aboriginal children contend with disproportionally high rates of Streptococcus pyogenes (Strep A) infected impetigo. The SToP Trial was a large stepped-wedge cluster randomised trial of See, Treat, and Prevent (SToP) skin health activities implemented between 2019 and 2022 in the Kimberley region of Western Australia, during which a decrease in impetigo was observed. We aim to evaluate the implementation of the SToP Trial activities and understand the relationship between the trial methodologies and outcomes observed.

Methods: A trial evaluation framework was developed, with the aim to assess whether the SToP activities were implemented as intended, and to gain insights into the implementation and practice necessary to translate this project more broadly. The evaluation employed a multi-methods approach, drawing on both quantitative (metadata relating to type and frequency of project activities, survey results) and qualitative (interview and yarning) data. The evaluation aimed to assess the delivery of the program in terms of implementation, degree of impact, and context.

Findings: Nine Kimberley communities participated in the SToP Trial between September 2018 and November 2022. During visits at the end of Steps 1 and 2 (October 2021 and October 2022, respectively), 152 people including 46 community members, 69 school staff members, 29 clinic staff members and 8 other service providers participated in a combination of individual and group interviews/yarns. Findings indicate the SToP Trial and associated activities existed and were completed within a culturally complex context with competing health and socioeconomic priorities while retaining specificity to each involved community. Acceptance and uptake of community activities was high, reflected in a marked decrease in skin infection during the Trial period. Trial activities including increased skin surveillance, staff training, availability of study treatment, environmental health initiatives and health promotion could not individually be linked to this improvement in skin health.

Interpretation: The leadership and guidance of community leaders, families, and regional Kimberley partners contributed to the Trial succeeding in its intended delivery of activities. Similar projects should prioritise a co-designed community-wide, holistic approach to health issues.

Funding: This trial was funded by the WA Department of Health, Australian National Health and Medical Research Council (NHMRC), and Healthway.

Keywords: Impetigo; Indigenous health; Randomised controlled trial; Remote health; Scabies; Skin health; Streptococcus pyogenes.

PubMed Disclaimer

Conflict of interest statement

All authors declare that they have no conflicts of interest.

Figures

Fig. 1
Fig. 1
See, Treat and Prevent activity delivery details and intended timeline – that was disrupted due to the global COVID-19 pandemic (2020–2023).
Fig. 2
Fig. 2
Frequency and degree of SToP Trial activities completed.
Fig. 3
Fig. 3
Frequency of sulfamethoxazole-trimethoprim and benzathine benzylpenicillin intramuscular injection prescription for the treatment of skin sores.
Fig. 4
Fig. 4
Frequency of ivermectin and permethrin prescription for the treatment of scabies.
Fig. 5
Fig. 5
Observed skin-related clinic presentations per week (all ages).

References

    1. Phillips-Beck W., Sinclair S., Campbell R., et al. Early-life origins of disparities in chronic diseases among Indigenous youth: pathways to recovering health disparities from intergenerational trauma. J Dev Orig Health Dis. 2019;10(1):115–122. - PubMed
    1. Thomas H.M.M., Enkel S., McRae T., et al. Skin health in northern Australia. Microbiol Aust. 2022;43(3):98–103.
    1. May P.J., Bowen A.C., Carapetis J.R. The inequitable burden of Group A streptococcal diseases in Indigenous Australians. Med J Aust. 2016;205(5):201–203. - PubMed
    1. Bowen A.C., Mahe A., Hay R.J., et al. The global epidemiology of impetigo: a systematic review of the population prevalence of impetigo and pyoderma. PLoS One. 2015;10(8) - PMC - PubMed
    1. Abdalla T., Hendrickx D., Fathima P., et al. Hospital admissions for skin infections among Western Australian children and adolescents from 1996 to 2012. PLoS One. 2017;12(11) - PMC - PubMed

LinkOut - more resources